메뉴 건너뛰기




Volumn 49, Issue 9 SUPPL., 2011, Pages

The clinical predictive value (or lack thereof) of the results of in vitro antimicrobial susceptibility tests

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CEFOPERAZONE; CEFOTAXIME; MEROPENEM;

EID: 80053185902     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00580-11     Document Type: Conference Paper
Times cited : (108)

References (24)
  • 3
    • 0025981930 scopus 로고
    • Correlations between therapeutic response of leukemias and in vitro drug sensitivity assay
    • Bosanquet, E. G. 1991. Correlations between therapeutic response of leukemias and in vitro drug sensitivity assay. Lancet 337:711-714.
    • (1991) Lancet , vol.337 , pp. 711-714
    • Bosanquet, E.G.1
  • 6
    • 62949178700 scopus 로고    scopus 로고
    • Effect of differences in MIC values on clinical outcomes in patients with blood stream infection caused by Gram-negative organisms treated with levofloxacin
    • Defife, R., M. H. Scheetz, J. M. Feinglass, M. J. Psotelnick, and K. Scarsi. 2009. Effect of differences in MIC values on clinical outcomes in patients with blood stream infection caused by Gram-negative organisms treated with levofloxacin. Antimicrob. Agents Chemother. 53:1074-1079.
    • (2009) Antimicrob. Agents Chemother. , vol.53 , pp. 1074-1079
    • Defife, R.1    Scheetz, M.H.2    Feinglass, J.M.3    Psotelnick, M.J.4    Scarsi, K.5
  • 7
    • 0026704883 scopus 로고
    • In vitro activity of loracarbef and effects of susceptibility test methods
    • Doern, G. V. 1992. In vitro activity of loracarbef and effects of susceptibility test methods. Am. J. Med. 92:7S-15S.
    • (1992) Am. J. Med. , vol.92
    • Doern, G.V.1
  • 8
    • 0029085669 scopus 로고
    • Interpretive criteria for in vitro antimicrobial susceptibility tests
    • Doern, G. V. 1995. Interpretive criteria for in vitro antimicrobial susceptibility tests. Rev. Med. Microbiol. 6:126-136.
    • (1995) Rev. Med. Microbiol. , vol.6 , pp. 126-136
    • Doern, G.V.1
  • 9
    • 66949131416 scopus 로고    scopus 로고
    • Short-term and medium-term outcomes of quinolone- resistant Campylobacter infection
    • Evans, M. R., et al. 2009. Short-term and medium-term outcomes of quinolone- resistant Campylobacter infection. Clin. Infect. Dis. 48:1500-1506.
    • (2009) Clin. Infect. Dis. , vol.48 , pp. 1500-1506
    • Evans, M.R.1
  • 11
    • 0019342866 scopus 로고
    • Worldwide clinical experience with cefoperazone
    • Gerber, A. U., and W. A. Craig. 1981. Worldwide clinical experience with cefoperazone. Drugs 22:108-118.
    • (1981) Drugs , vol.22 , pp. 108-118
    • Gerber, A.U.1    Craig, W.A.2
  • 12
    • 0024387119 scopus 로고
    • Antibiotic therapy for Pseudomonas aeruginosa bacteremia: Outcome correlations in a prospective study of 200 patients
    • Hilf, M., et al. 1989. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am. J. Med. 87:541-546.
    • (1989) Am. J. Med. , vol.87 , pp. 541-546
    • Hilf, M.1
  • 13
    • 0030797608 scopus 로고    scopus 로고
    • Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: Analysis of the correlations between in vitro test results and clinical response
    • DOI 10.1016/S0732-8893(97)00013-8, PII S0732889397000138
    • Jones, R. N., and M. N. Dudley. 1997. Microbiological and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/ sulbactam: analysis of the correlations between in vitro test results and clinical response. Diagn. Microbiol. Infect. Dis. 28:5-18. (Pubitemid 27314865)
    • (1997) Diagnostic Microbiology and Infectious Disease , vol.28 , Issue.1 , pp. 5-18
    • Jones, R.N.1    Dudley, M.N.2
  • 14
    • 80053217117 scopus 로고    scopus 로고
    • Molecular detection of resistance determinants
    • Ledeboer, N. A., and R. L. Hodinka. 2011. Molecular detection of resistance determinants. J. Clin. Microbiol. 49(Suppl.):S20-S24.
    • (2011) J. Clin. Microbiol. , vol.49 , Issue.SUPPL.
    • Ledeboer, N.A.1    Hodinka, R.L.2
  • 16
    • 0037232281 scopus 로고    scopus 로고
    • Detection and treatment of bloodstream infection: Laboratory reporting and antimicrobial management
    • DOI 10.1128/JCM.41.1.495-497.2003
    • Munson, E. L., D. J. Diekema, S. E. Beekmann, K. C. Chapin, and G. V. Doern. 2003. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J. Clin. Microbiol. 41:495-497. (Pubitemid 36098632)
    • (2003) Journal of Clinical Microbiology , vol.41 , Issue.1 , pp. 495-497
    • Munson, E.L.1    Diekema, D.J.2    Beekmann, S.E.3    Chapin, K.C.4    Doern, G.V.5
  • 17
    • 80053198237 scopus 로고
    • Analysis of the clinical predictive value of quantitative and qualitative susceptibility tests with cefotaxime
    • abstr. 545
    • Murray, P. R., R. Jones, and W. Novick. 1983. Analysis of the clinical predictive value of quantitative and qualitative susceptibility tests with cefotaxime. Abstr. 23rd Intersci. Conf. Antimicrob. Agents Chemother. abstr. 545, p. 182.
    • (1983) Abstr. 23rd Intersci. Conf. Antimicrob. Agents Chemother. , pp. 182
    • Murray, P.R.1    Jones, R.2    Novick, W.3
  • 18
    • 0034465384 scopus 로고    scopus 로고
    • Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: Findings of a multicenter prospective observational trial
    • Nguyen, M. H., V. L. Yu, and A. J. Morris. 2000. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin. Infect. Dis. 30:870-876.
    • (2000) Clin. Infect. Dis. , vol.30 , pp. 870-876
    • Nguyen, M.H.1    Yu, V.L.2    Morris, A.J.3
  • 19
    • 0037108380 scopus 로고    scopus 로고
    • Has antifungal susceptibility testing come of age?
    • DOI 10.1086/342384
    • Rex, J. H., and M. A. Pfaller. 2002. Has antifungal susceptibility testing come of age? Clin. Infect. Dis. 35:982-989. (Pubitemid 35178316)
    • (2002) Clinical Infectious Diseases , vol.35 , Issue.8 , pp. 982-989
    • Rex, J.H.1    Pfaller, M.A.2
  • 20
    • 0021191660 scopus 로고
    • Acute cystitis: A prospective study of laboratory tests and duration of therapy
    • Schultz, H. J., L. A. McCaffrey, T. F. Keys, and F. T. Nobrega. 1984. Acute cystitis: a prospective study of laboratory tests and duration of therapy. Mayo Clin. Proc. 59:391-397. (Pubitemid 14117996)
    • (1984) Mayo Clinic Proceedings , vol.59 , Issue.6 , pp. 391-397
    • Schultz, H.J.1    McCaffrey, L.A.2    Keys, T.F.3    Nobrega, F.T.4
  • 21
    • 0026511688 scopus 로고
    • Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: A retrospective analysis
    • Snydman, D. R., G. J. Cuchural, L. McDermott, and M. Gill. 1992. Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis. Antimicrob. Agents Chemother. 36:540-544.
    • (1992) Antimicrob. Agents Chemother. , vol.36 , pp. 540-544
    • Snydman, D.R.1    Cuchural, G.J.2    McDermott, L.3    Gill, M.4
  • 22
    • 0020595174 scopus 로고
    • Discrepancies between in vitro activity and in vivo response to antimicrobial agents
    • Washington, J. A. 1983. Discrepancies between in vitro activity and in vivo response to antimicrobial agents. Diagn. Microbiol. Infect. Dis. 1:25-31.
    • (1983) Diagn. Microbiol. Infect. Dis. , vol.1 , pp. 25-31
    • Washington, J.A.1
  • 23
    • 0020667691 scopus 로고
    • The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults
    • Weinstein, M. P., J. R. Murray, L. B. Reller, and K. A. Lichtenstein. 1983. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. Rev. Infect. Dis. 5:54-70.
    • (1983) Rev. Infect. Dis. , vol.5 , pp. 54-70
    • Weinstein, M.P.1    Murray, J.R.2    Reller, L.B.3    Lichtenstein, K.A.4
  • 24
    • 77953097553 scopus 로고    scopus 로고
    • Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of communityonset bacteremic urinary tract infections
    • Yang, Y. S., et al. 2010. Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of communityonset bacteremic urinary tract infections. J. Microbiol. Immunol. Infect. 43:194-199.
    • (2010) J. Microbiol. Immunol. Infect. , vol.43 , pp. 194-199
    • Yang, Y.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.